U.S. Dnases Market Size & Outlook, 2023-2030
U.S. dnases market, 2018-2030 (US$M)
Related Markets
U.S. dnases market highlights
- The U.S. dnases market generated a revenue of USD 81.2 million in 2023 and is expected to reach USD 142.2 million by 2030.
- The U.S. market is expected to grow at a CAGR of 8.3% from 2024 to 2030.
- In terms of segment, biopharmaceutical processing was the largest revenue generating application in 2023.
- Other Applications is the most lucrative application segment registering the fastest growth during the forecast period.
Dnases market data book summary
| Market revenue in 2023 | USD 81.2 million |
| Market revenue in 2030 | USD 142.2 million |
| Growth rate | 8.3% (CAGR from 2023 to 2030) |
| Largest segment | Biopharmaceutical processing |
| Fastest growing segment | Other Applications |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Biopharmaceutical Processing, Other Applications |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Agilent Technologies Inc, Promega, New England Biolabs, RayBiotech, Qiagen NV, Takara Bio Inc, Abnova, Worthington Enterprises Inc, MyBiosource, Sino Biological, Biovision, Calzyme, ArcticZymes Technologies, MBL International Corporation, BPS Bioscience Inc., Bio-Techne Corp, ABclonal |
Other key industry trends
- In terms of revenue, U.S. accounted for 33.5% of the global dnases market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In North America, U.S. dnases market is projected to lead the regional market in terms of revenue in 2030.
- Canada is the fastest growing regional market in North America and is projected to reach USD 15.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
DNAses Market Scope
DNAses Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
U.S. dnases market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dnases market will help companies and investors design strategic landscapes.
Biopharmaceutical processing was the largest segment with a revenue share of 75.37% in 2023. Horizon Databook has segmented the U.S. dnases market based on biopharmaceutical processing, other applications covering the revenue growth of each sub-segment from 2018 to 2030.
- U.S. DNAses Application Outlook (Revenue, USD Million, 2018-2030)
- Biopharmaceutical Processing
- Oligonucleotide synthesis
- mRNA Production
- Other Applications
Reasons to subscribe to U.S. dnases market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of U.S. dnases market databook
-
Our clientele includes a mix of dnases market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. dnases market, including forecasts for subscribers. This country databook contains high-level insights into U.S. dnases market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
U.S. dnases market size, by application, 2018-2030 (US$M)
U.S. DNAses Market Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
